| 4-AHP | 4-Amino-3-hydroxyphenylalanine |
| Anti-PD | Anti-programmed cell death protein |
| BRAF | B-Raf proto-oncogene serine/threonine kinase |
| CMC | Circulating melanoma cells |
| COMT | Catechol-O-methyl transferase |
| CSF | Cerebrospinal fluid |
| DHI | 5,6-Dihydroxyindole |
| DHICA | 5,6-Dihydroxyindole-2-carboxylic acid |
| EI | Erythema index |
| HD | Hemodialysis |
| HMB-45 | Human melanoma black-45 |
| HGF | Hepatocyte growth factor |
| 5H6MI2C | 5-Hydroxy-6-methoxyindole-2-carboxylic acid |
| 6H5MI2C | 6-Hydroxy-5-methoxyindole-2-carboxylic acid |
| ICAM-1 | Intercellular adhesion molecule-I |
| LDH | Lactate dehydrogenase |
| MI | Melanin index |
| MIA | Melanoma inhibitory activity |
| miRNA | microRNA |
| Nivo | Nivolumab |
| PB-DOPA | Protein-bound 3,4-dihydroxyphenylalanine |
| PB-5SCD | Protein-bound (PB)-5SCD |
| PD | Peritoneal dialysis |
| PD-1 | Anti-programmed cell death protein |
| RT | Radiotherapy |
| PMMB | Primary malignant melanoma of the breast |
| PMME | Primary melanoma of the esophagus |
| RT-PCR | Reverse transcription polymerase chain reaction |
| S100B | S100 calcium-binding protein B |
| 5SCD | 5-S-Cysteinyldopa |
| UV | Ultraviolet |